Showing results (11-20 of 107) with videos related to
Sort By:
Pageof 11
Journal of Global Antimicrobial Resistance|February 19, 2025
In vitro activity of aztreonam in combination with relebactam against gram-negative pathogens producing various serine and metallo-β-lactamasesKengo Hayashi, Masahiro Suzuki, Yoshikazu Ishii, et al.Global Health & Medicine|May 19, 2022
The first eleven cases of SARS-CoV-2 Omicron variant infection in Japan: A focus on viral dynamicsNobumasa Okumura, Shinya Tsuzuki, Sho Saito, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|February 13, 2024
Epidemiology of post-COVID conditions beyond 3 years and factors associated with their persistence longer than 2 years: A cross-sectional studyShinichiro Morioka, Mio Nikaido, Shinya Tsuzuki, et al.Global Health & Medicine|September 19, 2022
Evaluation of the representativeness of data in the COVID-19 Registry Japan during the first six waves of the epidemicKayoko Hayakawa, Yusuke Asai, Nobuaki Matsunaga, et al.Journal of Infection and Public Health|February 6, 2022
Risk factors associated with asymptomatic hypoxemia among COVID-19 patients: a retrospective study using the nationwide Japanese registry, COVIREGI-JPYutaro Akiyama, Shinichiro Morioka, Yusuke Asai, et al.BMC Infectious Diseases|December 4, 2023
Comparative effectiveness of tocilizumab vs standard care in patients with severe COVID-19-related pneumonia: a retrospective cohort study utilizing registry data as a synthetic controlYukari Uemura, Ryoto Ozaki, Tomohiro Shinozaki, et al.Respiratory Medicine Case Reports|June 12, 2023
Successful immunosuppressant-free treatment of a drug-induced sarcoidosis-like reaction caused by dupilumabSho Saito, Masamitsu Shimizu, Ryota Miyashita, et al.Global Health & Medicine|May 3, 2021
Investigator initiated clinical trial of remdesivir for the treatment of COVID-19 in JapanSho Saito, Kayoko Hayakawa, Ayako Mikami, et al.Global Health & Medicine|May 2, 2023
Association between SARS-CoV-2 anti-spike antibody titers and the development of post-COVID conditions: A retrospective observational studyYusuke Miyazato, Shinya Tsuzuki, Akihiro Matsunaga, et al.BMJ Open|June 16, 2021
Risk factors for severity on admission and the disease progression during hospitalisation in a large cohort of patients with COVID-19 in JapanMari Terada, Hiroshi Ohtsu, Sho Saito, et al.Pageof 11